sing markers of coronary artery disease to gain information about the disease

Not Applicable

Not yet recruiting

• Conditions: Health Condition 1: I222- Subsequent non-ST elevation (NSTEMI) myocardial infarction

• Registration Number: CTRI/2019/03/017933
• Lead Sponsor: ICMR

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Patients presenting with Acute Coronary syndromes (STEMI, NSTEMI, Unstable Angina with >=10 minutes of angina or anginal equivalent consistent with unstable angina or myocardial infarction (MI) within 72 hours, with either elevated cardiac biomarkers (CK-MB or troponin) or ST-segment deviation of >1 mm in >=2 contiguous electrocardiographic leads) to EMOPD or OPD of the Department of Cardiology at GMCH-32, will be included.

Exclusion Criteria

1.Cardiogenic shock.

2.Left Ventricular Failure (Killip Class 3 or 4).

3.Serum creatinine >=2.5 mg/dl.

4.Known allergy, hypersensitivity or contraindication to aspirin, heparin, or contrast.

5.Significant gastrointestinal or urinary bleed within the past 6 weeks, coagulopathy or bleeding diathesis.

6.Deranged LFTs like bilirubin >1.5mg/dl and enzymes 2 to 3 times elevated above upper limit of normal.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Association of biomarkers of inflammation with the type of plaque morphology.Timepoint: 30 days.

Secondary Outcome Measures

Name	Time	Method
Correlation of the systemic biomarkers of inflammation and the coronary blood biomarkers of inflammation.Timepoint: 30 days.